China National Accord Medicines Corp Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.020x

China National Accord Medicines Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-425.23 Million ≈ $-62.23 Million USD) by net assets (CN¥21.55 Billion ≈ $3.15 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of China National Accord Medicines Corp Ltd (1998–2024)

Cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2024. This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000028 stock price and chart for real-time trading data and today's change.

China National Accord Medicines Corp Ltd Cash Flow Conversion Ratio Explained

China National Accord Medicines Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency. Also see China National Accord Medicines Corp Ltd (000028) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Pharma Reaserch Prod Co Ltd
KQ:214450
0.085x
Suzhou Crystal Clear Chemical Co Ltd
SHE:300655
0.062x
Global Blue Group Holding Ltd
NYSE:GB
0.190x
First Tracks Biotherapeutics
NASDAQ:TRAX
-0.189x
Neutron Holdings, Inc. Common Stock
NASDAQ:LIME
0.105x
Grupo Security
SN:SECURITY
0.531x
China Aluminum International Engineering Corp Ltd
SHG:601068
0.031x
Shenzhen Colibri Technologies Co Ltd
SHE:002957
0.026x

Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2024. Review China National Accord Medicines Corp Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥20.76 Billion
≈ $3.04 Billion
CN¥3.27 Billion
≈ $478.72 Million
0.158x +12.58%
2023-12-31 CN¥20.98 Billion
≈ $3.07 Billion
CN¥2.94 Billion
≈ $429.80 Million
0.140x +6.33%
2022-12-31 CN¥19.44 Billion
≈ $2.85 Billion
CN¥2.56 Billion
≈ $374.67 Million
0.132x +43.38%
2021-12-31 CN¥18.02 Billion
≈ $2.64 Billion
CN¥1.66 Billion
≈ $242.21 Million
0.092x +3.22%
2020-12-31 CN¥16.89 Billion
≈ $2.47 Billion
CN¥1.50 Billion
≈ $219.90 Million
0.089x -31.68%
2019-12-31 CN¥15.36 Billion
≈ $2.25 Billion
CN¥2.00 Billion
≈ $292.71 Million
0.130x +36.93%
2018-12-31 CN¥13.91 Billion
≈ $2.03 Billion
CN¥1.32 Billion
≈ $193.54 Million
0.095x -26.54%
2017-12-31 CN¥9.93 Billion
≈ $1.45 Billion
CN¥1.29 Billion
≈ $188.08 Million
0.129x -21.63%
2016-12-31 CN¥8.91 Billion
≈ $1.30 Billion
CN¥1.47 Billion
≈ $215.48 Million
0.165x -12.25%
2015-12-31 CN¥5.57 Billion
≈ $814.55 Million
CN¥1.05 Billion
≈ $153.35 Million
0.188x +214.64%
2014-12-31 CN¥4.85 Billion
≈ $709.89 Million
CN¥-796.70 Million
≈ $-116.58 Million
-0.164x -181.81%
2013-12-31 CN¥2.32 Billion
≈ $339.00 Million
CN¥465.03 Million
≈ $68.05 Million
0.201x +13.95%
2012-12-31 CN¥1.84 Billion
≈ $269.11 Million
CN¥323.96 Million
≈ $47.40 Million
0.176x +10.57%
2011-12-31 CN¥1.43 Billion
≈ $208.79 Million
CN¥227.32 Million
≈ $33.26 Million
0.159x -57.90%
2010-12-31 CN¥1.13 Billion
≈ $165.57 Million
CN¥428.16 Million
≈ $62.65 Million
0.378x +22.69%
2009-12-31 CN¥878.13 Million
≈ $128.50 Million
CN¥270.85 Million
≈ $39.63 Million
0.308x -18.77%
2008-12-31 CN¥649.37 Million
≈ $95.02 Million
CN¥246.58 Million
≈ $36.08 Million
0.380x +124.10%
2007-12-31 CN¥517.58 Million
≈ $75.74 Million
CN¥87.70 Million
≈ $12.83 Million
0.169x -55.91%
2006-12-31 CN¥472.90 Million
≈ $69.20 Million
CN¥181.73 Million
≈ $26.59 Million
0.384x +2.04%
2005-12-31 CN¥393.72 Million
≈ $57.61 Million
CN¥148.28 Million
≈ $21.70 Million
0.377x +3.53%
2004-12-31 CN¥358.20 Million
≈ $52.42 Million
CN¥130.30 Million
≈ $19.07 Million
0.364x +53.55%
2003-12-31 CN¥342.86 Million
≈ $50.17 Million
CN¥81.22 Million
≈ $11.89 Million
0.237x +175.64%
2002-12-31 CN¥334.70 Million
≈ $48.98 Million
CN¥28.76 Million
≈ $4.21 Million
0.086x -55.98%
2001-12-31 CN¥364.45 Million
≈ $53.33 Million
CN¥71.16 Million
≈ $10.41 Million
0.195x +828.36%
2000-12-31 CN¥405.06 Million
≈ $59.27 Million
CN¥8.52 Million
≈ $1.25 Million
0.021x -58.36%
1999-12-31 CN¥452.23 Million
≈ $66.18 Million
CN¥22.84 Million
≈ $3.34 Million
0.051x +334.65%
1998-12-31 CN¥448.25 Million
≈ $65.59 Million
CN¥5.21 Million
≈ $762.12K
0.012x --

About China National Accord Medicines Corp Ltd

SHE:000028 China Medical Distribution
Market Cap
$1.49 Billion
CN¥10.20 Billion CNY
Market Cap Rank
#6966 Global
#1369 in China
Share Price
CN¥21.02
Change (1 day)
+0.38%
52-Week Range
CN¥18.91 - CN¥27.00
All Time High
CN¥2829.45
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more